Evidence from experimental models of hypothyroidism has shown that LT4 alone may be unable to deliver an adequate amount of T3 to all tissues targeted by thyroid hormone action, while this can be achieved by combined LT4/LT3 therapy (73). This evidence concerns the gene TG and hypothyroidism.